Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on January 3, 2005. The report discloses corporate governance changes effective as of the filing date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
- Board Election: The Board of Directors elected James M. Cornelius, non-executive chairman of Guidant Corporation, as a new director. His election is effective immediately, and he will stand for election by stockholders at the Annual Meeting in May 2005.
- Bylaw Amendment: The Board amended Section 15(a) of the Company's Bylaws to increase the number of directors from ten to eleven.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is limited to the announcement of the director election and the corresponding bylaw amendment.
Key Facts for Investor Verification
- James M. Cornelius has joined the Board of Directors effective January 3, 2005.
- The total number of directors on the Board has been increased to eleven.
- Mr. Cornelius will be subject to a stockholder vote at the May 2005 Annual Meeting.